Bessemer Group’s Niagen Bioscience NAGE Stock Holding History

Bessemer Group’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-115,800	Closed	-$532K	–	1704
2020 Q2	$532K	Buy	+115,800	New	+$518K	﹤0.01%	951

Other funds holding NAGE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sycale Advisors New York $201M AUM 2.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bessemer Group's NAGE Position: Q3 2020 in Review

Bessemer Group sold out of Niagen Bioscience (NAGE) in Q3 2020, closing a stake of 115,800 shares — an estimated $532K sold.

Bessemer Group first reported a position in NAGE in Q2 2020 and held it in 1 quarter. The position peaked at $532K in Q2 2020. 77 funds tracked by Wall St. Rank hold NAGE as of Q3 2020.

Bessemer Group reported no remaining Niagen Bioscience position as of Q3 2020 after selling out during the quarter.
Bessemer Group sold 115,800 Niagen Bioscience shares in Q3 2020, an estimated $532K.
Bessemer Group first reported a position in Niagen Bioscience in Q2 2020 and held it in 1 quarter.
Bessemer Group's Niagen Bioscience position peaked at $532K in Q2 2020.
77 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2020.

Based on Bessemer Group's 13F filing for Q3 2020, filed 12 Nov 2020.